Cargando…

Systems Toxicology: Real World Applications and Opportunities

[Image: see text] Systems Toxicology aims to change the basis of how adverse biological effects of xenobiotics are characterized from empirical end points to describing modes of action as adverse outcome pathways and perturbed networks. Toward this aim, Systems Toxicology entails the integration of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartung, Thomas, FitzGerald, Rex E., Jennings, Paul, Mirams, Gary R., Peitsch, Manuel C., Rostami-Hodjegan, Amin, Shah, Imran, Wilks, Martin F., Sturla, Shana J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2017
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396025/ https://www.ncbi.nlm.nih.gov/pubmed/28362102 http://dx.doi.org/10.1021/acs.chemrestox.7b00003

Ejemplares similares

Systems Toxicology: From Basic Research to Risk Assessment
por: Sturla, Shana J., et al.
Publicado: (2014)

Reverse Translation in PBPK and QSP: Going Backwards in Order to Go Forward With Confidence
por: Rostami‐Hodjegan, Amin
Publicado: (2017)

Interventions designed to reduce implicit prejudices and implicit stereotypes in real world contexts: a systematic review
por: FitzGerald, Chloë, et al.
Publicado: (2019)

Quality Assurance of PBPK Modeling Platforms and Guidance on Building, Evaluating, Verifying and Applying PBPK Models Prudently under the Umbrella of Qualification: Why, When, What, How and By Whom?
por: Frechen, Sebastian, et al.
Publicado: (2022)

Opening a debate on open‐source modeling tools: Pouring fuel on fire versus extinguishing the flare of a healthy debate
por: Rostami‐Hodjegan, Amin, et al.
Publicado: (2021)

Proteomics for systems toxicology
por: Titz, Bjoern, et al.
Publicado: (2014)

Precision medicine technology hype or reality? The example of computer-guided dosing
por: Polasek, Thomas M., et al.
Publicado: (2019)

Editorial: Precision Medicine: Impact of Cytochromes P450 and Transporters Genetic Polymorphisms, Drug-Drug Interactions, Disease on Safety and Efficacy of Drugs
por: Daali, Youssef, et al.
Publicado: (2022)

Advancing Risk Assessment through the Application of Systems Toxicology
por: Sauer, John Michael, et al.
Publicado: (2016)

Evolutionary toxicology in an omics world
por: Oziolor, Elias M., et al.
Publicado: (2017)

Novel minimal physiologically-based model for the prediction of passive tubular reabsorption and renal excretion clearance
por: Scotcher, Daniel, et al.
Publicado: (2016)

Assessing Potential Drug–Drug Interactions Between Dabigatran Etexilate and a P‐Glycoprotein Inhibitor in Renal Impairment Populations Using Physiologically Based Pharmacokinetic Modeling
por: Doki, Kosuke, et al.
Publicado: (2019)

Application of the Nested Enzyme‐Within‐Enterocyte (NEWE) Turnover Model for Predicting the Time Course of Pharmacodynamic Effects
por: Takita, Hiroyuki, et al.
Publicado: (2020)

Proof of Concept in Assignment of Within-Subject Variability During Virtual Bioequivalence Studies: Propagation of Intra-Subject Variation in Gastrointestinal Physiology Using Physiologically Based Pharmacokinetic Modeling
por: Bego, Margareta, et al.
Publicado: (2022)

Clinical asthma phenotypes in the real world: opportunities and challenges
por: Bostantzoglou, Clementine, et al.
Publicado: (2015)

Real-world data in the United Kingdom: opportunities and challenges
por: McDonald, Laura, et al.
Publicado: (2016)

Real‐World Data: An Unrealized Opportunity in Global Health?
por: Barrett, Jeffrey S., et al.
Publicado: (2019)

Delineating the Role of Various Factors in Renal Disposition of Digoxin through Application of Physiologically Based Kidney Model to Renal Impairment Populations
por: Scotcher, Daniel, et al.
Publicado: (2017)

Precision dosing to avoid adverse drug reactions
por: Polasek, Thomas M., et al.
Publicado: (2019)

Seeing what is behind the smokescreen: A systematic review of methodological aspects of smoking interaction studies over the last three decades and implications for future clinical trials
por: Hermann, Robert, et al.
Publicado: (2023)

A Toxicology for the 21st Century—Mapping the Road Ahead
por: Hartung, Thomas
Publicado: (2009)

Biotherapeutics: Challenges and Opportunities for Predictive Toxicology of Monoclonal Antibodies
por: Johnson, Dale E.
Publicado: (2018)

Deconvolution and IVIVC: Exploring the Role of Rate-Limiting Conditions
por: Margolskee, Alison, et al.
Publicado: (2015)

Application of Physiologically Based Pharmacokinetic (PBPK) Modeling Within a Bayesian Framework to Identify Poor Metabolizers of Efavirenz (PM), Using a Test Dose of Efavirenz
por: Chetty, Manoranjenni, et al.
Publicado: (2018)

Effect of Chronic Kidney Disease on the Renal Secretion via Organic Anion Transporters 1/3: Implications for Physiologically‐Based Pharmacokinetic Modeling and Dose Adjustment
por: Tan, Shawn Pei Feng, et al.
Publicado: (2022)

Altered Bioavailability and Pharmacokinetics in Crohn’s Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs
por: Alrubia, Sarah, et al.
Publicado: (2022)

Collaborative care in real-world settings: barriers and opportunities for sustainability
por: Sanchez, Katherine
Publicado: (2017)

The Alignment of Real-World Evidence and Digital Health: Realising the Opportunity
por: Khosla, Sajan, et al.
Publicado: (2021)

Quantifying gut wall metabolism: methodology matters
por: Hatley, Oliver J.D., et al.
Publicado: (2017)

Optimization of intestinal microsomal preparation in the rat: A systematic approach to assess the influence of various methodologies on metabolic activity and scaling factors
por: Hatley, Oliver J.D., et al.
Publicado: (2017)

Considerations and Caveats when Applying Global Sensitivity Analysis Methods to Physiologically Based Pharmacokinetic Models
por: Liu, Dan, et al.
Publicado: (2020)

Editorial: Advances in and applications of predictive toxicology: 2022
por: Najjar, Abdulkarim, et al.
Publicado: (2023)

Systems Toxicology Approach for Assessing Developmental Neurotoxicity in Larval Zebrafish
por: Li, Roman A., et al.
Publicado: (2021)

Real-world evidence and product development: Opportunities, challenges and risk mitigation
por: Naidoo, Poobalan, et al.
Publicado: (2021)

Roles of real-world evidence in severe asthma treatment: challenges and opportunities
por: Lee, Youngsoo, et al.
Publicado: (2023)

Missed opportunities in the diagnosis of heart failure: a real‐world assessment
por: Ferreira, João Pedro, et al.
Publicado: (2023)

3S – Systematic, Systemic, and Systems Biology and Toxicology
por: Smirnova, Lena, et al.
Publicado: (2018)

Probabilistic Risk Assessment – The Keystone for the Future of Toxicology
por: Maertens, Alexandra, et al.
Publicado: (2022)

Nanomaterials Versus Ambient Ultrafine Particles: An Opportunity to Exchange Toxicology Knowledge
por: Stone, Vicki, et al.
Publicado: (2017)

Intranasal drug delivery: opportunities and toxicologic challenges during drug development
por: Keller, Lea-Adriana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8cmm1osg4l9im7uhcrfnbqihcg